Lipid mediator class switching during acute inflammation: signals in resolution
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Leukotrienes (LTs) and prostaglandins (PGs) amplify acute inflammation, whereas lipoxins (LXs) have unique anti-inflammatory actions. Temporal analyses of these eicosanoids in clinical and experimental exudates showed early coordinate appearance of LT and PG with polymorphonuclear neutrophil (PMN) recruitment. This was followed by LX biosynthesis, which was concurrent with spontaneous resolution. Human peripheral blood PMNs exposed to PGE2 (as in exudates) switched eicosanoid biosynthesis from predominantly LTB4 and 5-lipoxygenase (5-LO)-initiated pathways to LXA4, a 15-LO product that "stopped" PMN infiltration. These results indicate that first-phase eicosanoids promote a shift to anti-inflammatory lipids: functionally distinct lipid-mediator profiles switch during acute exudate formation to "reprogram" the exudate PMNs to promote resolution.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prostaglandin E2 (PGE2) and D2 rapidly initiate the resolution process by inducing the expression of lipid mediators with both anti-inflammatory and pre-resolution functions, e.g., lipoxins [96, 97], resolvins and protectins [98–100], a process known as lipid-mediator class switch [97].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [97]
Citations
Cites
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Godson, C., Mitchell, S., Harvey, K., Petasis, N. A., Hogg, N., & Brady, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1663 · Cited by 638
Inflammation: Basic Principles and Clinical Correlates
Ehrlich, G. E. (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.283.1.123 · Cited by 622
Shinmura, K., Tang, X.-L., Wang, Y., Xuan, Y.-T., Liu, S.-Q., Takano, H., Bhatnagar, A., & Bolli, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10197 · Cited by 381
Swan, S. K., Rudy, D. W., Lasseter, K. C., Ryan, C. F., Buechel, K. L., Lambrecht, L. J., Pinto, M. B., Dilzer, S. C., Obrda, O., Sundblad, K. J., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00002 · Cited by 339
Design of Lipoxin A4 Stable Analogs That Block Transmigration and Adhesion of Human Neutrophils
Serhan, C. N., Maddox, J. F., Petasis, N. A., Akritopoulou-Zanze, I., Papayianni, A., Brady, H. R., Colgan, S. P., & Madara, J. L. (1995) · Biochemistry · doi:10.1021/bi00044a041 · Cited by 327
Self-citationActivation of the NF-κB Pathway by Inflammatory Stimuli in Human Neutrophils
McDonald, P. P., Bald, A., & Cassatella, M. A. (1997) · Blood · doi:10.1182/blood.v89.9.3421 · Cited by 324
Prostaglandins, Aspirin-like Drugs and the Oedema of Inflammation
MONCADA, S., FERREIRA, S. H., & VANE, J. R. (1973) · Nature · doi:10.1038/246217a0 · Cited by 312 · cited 1×
“Although PGE 2 induces reactions that mediate several of the cardinal features of inflammation (for example, edem”
BackgroundTessier, P. A., Naccache, P. H., Clark-Lewis, I., Gladue, R. P., Neote, K. S., & McColl, S. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3595 · Cited by 233
Research works printed but not linked: 2
- Light, R. W. Pleural Diseases (Lea & Febiger, Philadelphia, 1990).
- Clish, C. B. et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl Acad Sci USA 96, 8247–8252 (1999). · DOI · Paper page
Cited by
Items 801–900 of 1,000
Małachowa, N., Kobayashi, S. D., Quinn, M. T., & DeLeo, F. R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00259 · Cited by 33
“, neutrophil–endothelial cell) interaction (50, 53).”
BackgroundRajakariar, R., Newson, J., Jackson, E. K., Sawmynaden, P., Smith, A. M., Rahman, F. Z., Yaqoob, M., & Gilroy, D. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801739 · Cited by 26
“PGE2 was measured by enzyme immunoassay (Cayman Chemical), whereas lipoxin A4 was quantified by ELISA (Neogen).”
BackgroundInfluentialMolecular Circuits of Resolution in Renal Disease
Börgeson, E., & Godson, C. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.120 · Cited by 27
“The signaling pathways inducing PGE2 and PGD2 formation actively switch the production of lipid mediators from proinflammatory to proresolving by inducing 15-lipoxygenase (LO), which is required for production of LXs, protectins, and resolvins[5].”
BackgroundLi, X., Mazaleuskaya, L. L., Ballantyne, L. L., Meng, H., FitzGerald, G. A., & Funk, C. D. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m080028 · Cited by 29
“There is also a temporal sequence of events in acute inflammation, governed by eicosanoid profile switching (18).”
BackgroundMaciejewska, D., Marlicz, W. M., Ryterská, K., Banaszczak, M., Jamioł-Milc, D., & Stachowska, E. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/5856201 · Cited by 28
Davies, C. L., Patir, A., & McColl, B. W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01048 · Cited by 26
Specialized pro-resolving mediators in diabetes: novel therapeutic strategies
Brennan, E. P., Mohan, M., Andrews, D. C., Bose, M., & Kantharidis, P. (2019) · Clinical Science · doi:10.1042/cs20190067 · Cited by 30
Bioactive Lipids in MSCs Biology: State of the Art and Role in Inflammation
Casati, S., Giannasi, C., Niada, S., Bergamaschi, R. F., Orioli, M., & Brini, A. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031481 · Cited by 26
Lipoxins and synthetic lipoxin mimetics: Therapeutic potential in renal diseases
Andrews, D. C., & Godson, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158940 · Cited by 29
The Effect and Mechanism of Lipoxin A4 on Neutrophil Function in LPS-Induced Lung Injury
Pan, W., Hu, X., Chen, B., Xu, Q.-C., & Mei, H. (2022) · Inflammation · doi:10.1007/s10753-022-01666-5 · Cited by 26
Higgins, G., Ringholz, F., Buchanan, P., McNally, P., & Urbach, V. (2015) · BioMed Research International · doi:10.1155/2015/781087 · Cited by 29
Potential role of omega‐3‐derived resolution mediators in metabolic inflammation
White, P. J., & Marette, A. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2013.112 · Cited by 29
New insights into eicosanoid biosynthetic pathways: implications for arthritis
Kojima, F., Kapoor, M., Kawai, S., & Crofford, L. J. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.2.277 · Cited by 25
Is multiple sclerosis a proresolution deficiency disorder?
Das, U. N. (2012) · Nutrition · doi:10.1016/j.nut.2011.12.016 · Cited by 27
“Lipoxins, resolvins, protectins, and maresins are not only antiinflammatory in nature but also enhance wound healing, resolve inflammation, and have cytoprotective and neuroprotective actions [2–7].”
BackgroundInfluentialRoles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation
Recchiuti, A., Isopi, E., Romano, M., & Mattoscio, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186637 · Cited by 27
“Notably, SPM biosynthesis can be modulated by pro-inflammatory mediators, for instance PGE2, generated during the onset of the inflammatory response [52], indicating that resolution is programmed from the beginning of the inflammatory reaction.”
BackgroundSaraiva, T. D. L., Morais, K. L. P., Pereira, V. B., de Azevedo, M. S. P., Rocha, C., Prosperi, C., Gomes-Santos, A. C., Bermúdez‐Humarán, L. G., Faria, A. M. C., Blottière, H. M., et al. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666141113123502 · Cited by 26
“This enzyme is found in endothelial/epithelial cells and plays a key role in the oxidative metabolism of arachidonic acid, producing the lipoxins, lipid mediators with potent anti-inflammatory actions [7-9].”
Background1‐Tetradecanol Complex: Therapeutic Actions in Experimental Periodontitis
Hastürk, H., Goguet, E., Blackwood, A., Andry, C., & Kantarcı, A. (2009) · Journal of Periodontology · doi:10.1902/jop.2009.090002 · Cited by 25
Lipoxins: update and impact of endogenous pro-resolution lipid mediators
O'Meara, S. J., Rodgers, K., & Godson, C. (2007) · Springer eBooks · doi:10.1007/112_2006_0606 · Cited by 26
The role of the lipidome in obesity-mediated colon cancer risk
Jain, R., Pickens, C. A., & Fenton, J. I. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.02.015 · Cited by 26
Alvarenga, D. M., Mattos, M. S., Lopes, M. E., Marchesi, S. C., de Araujo, A., Nakagaki, B. N., Santos, M. M., David, B. A., Lacerda, V. A. D. S., de Carvalho, É., et al. (2018) · Cells · doi:10.3390/cells7120247 · Cited by 29
“Consistent with this, there is a growing body of evidence suggesting that neutrophils play a fundamental role in the reparation phase of inflammation by producing pro-resolutive mediators such as lipoxins [23], scavenging pro-inflammatory cytokines [24,25] and the pro-resolutive mediator AnxA1 [26].”
BackgroundDalli, J., Gómez, E. A., & Jouvene, C. C. (2022) · Biomolecules · doi:10.3390/biom12030353 · Cited by 28
Fitzgerald, H., Bonin, J. L., Khan, S., Eid, M., Sadhu, S., Rahtes, A., Lipscomb, M., Biswas, N., Decker, C., Nabage, M., et al. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.08.011 · Cited by 28
Anti-inflammatory drugs, eicosanoids and the annexin A1/FPR2 anti-inflammatory system
Yazid, S., Norling, L. V., & Flower, R. (2011) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2011.11.005 · Cited by 27
15-Epi-lipoxin A4 inhibits the progression of endometriosis in a murine model
Chen, Q., Zhou, W., Pu, D., Huang, Q.-S., Tian, L., & Chen, Q. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.01.107 · Cited by 25
Analysis of endogenous lipids during intestinal wound healing
Lee, Y., Choo, J., Kim, S. J., Heo, G., Pothoulakis, C., Kim, Y., & Im, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183028 · Cited by 26
“During the initiation of inflammation, prostaglandins and leukotrienes increase, and then lipid mediator class switching occurs to terminate inflammation and to stimulate the resolution process [23].”
BackgroundResultBotten, N., Hodges, R. R., Li, D., Bair, J. A., Shatos, M. A., Utheim, T. P., Serhan, C. N., & Dartt, D. A. (2019) · The FASEB Journal · doi:10.1096/fj.201802467r · Cited by 25
“Production of proinflammatory arachidonic acid derivatives undergo a class switch topromote sequential biosynthesis of endogenous SPMs to terminate inflammation, induce homeostasis, and limit tissue damage and fibrosis (5, 6).”
BackgroundSelf-citationThe Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease
Briottet, M., Shum, M., & Urbach, V. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01290 · Cited by 26
“…in the class-switching from the pro-inflammatory lipid mediator LTB4 toward SPMs. Isolated PMNs exposed to PGE2 (to mimic exudates) switched eicosanoid biosynthesis from predominantly LTB4 and 5LO-initiated pathways to LXA4, which is a 15LO product that stops PMN infiltration (Levy et al., 2001).”
BackgroundResolution of chronic inflammation and cancer
Tezcan, G., Yakar, N., Hastürk, H., Dyke, T. E. V., & Kantarcı, A. (2024) · Periodontology 2000 · doi:10.1111/prd.12603 · Cited by 34
Neutrophils secrete exosome-associated DNA to resolve sterile acute inflammation
Arya, S. B., Collie, S. P., Xu, Y., Fernandez, M., Sexton, J. Z., Mosalaganti, S., Coulombe, P. A., & Parent, C. A. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01671-4 · Cited by 26
“128–130), which is crucial for neutrophil clearance by reverse transmigration 131–133 .”
Otoki, Y., Metherel, A. H., Pedersen, T. L., Yang, J., Hammock, B. D., Bazinet, R. P., Newman, J. W. I., & Taha, A. Y. (2019) · Lipids · doi:10.1002/lipd.12197 · Cited by 24
“, 2016), and the resolution of inflammation (Levy et al., 2001; Orr et al., 2013; Serhan et al., 2002).”
BackgroundTang, X., Liu, L., Miao, Z., Zhang, J., Cai, X., Zhao, B., Chen, G., Schultzberg, M., Zhao, Y., & Wang, X. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.06.231 · Cited by 28
Alqahtani, S., Xia, L., & Shannahan, J. H. (2022) · Particle and Fibre Toxicology · doi:10.1186/s12989-022-00495-6 · Cited by 26
“Disruption of these lipid signaling pathways can result in inefficient or failure of resolution causing chronic inflammation and disease progression [14, 15].”
BackgroundImmune system in renal injury and repair: Burning the candle from both ends?
Goligorsky, M. S. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.05.011 · Cited by 23
Lütfioğlu, M., Aydoğdu, A., Sakallıoğlu, E. E., Alaçam, H., & Pamuk, F. (2015) · Journal of Periodontal Research · doi:10.1111/jre.12324 · Cited by 32
Holen, E., He, J., Espe, M., Chen, L., & Araujo, P. W. (2015) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2015.05.017 · Cited by 23
“AA derived mammalian prostaglandins have previously been considered proinflammatory, but it turns out that they also could have opposing effects as PGE2 inhibits LOX5 and decrease the production of 4 series leukotrienes [20] and could induce 15 LOX that promote lipoxin production, a mediator with anti-inflammatory eff…”
BackgroundPiotrowska-Tomala, K. K., Bah, M. M., Jankowska, K., Łukasik, K., Warmowski, P., Galvão, A. M., & Skarzynski, D. J. (2015) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2015.03.001 · Cited by 26
Oxymetazoline Inhibits and Resolves Inflammatory Reactions in Human Neutrophils
Beck‐Speier, I., Oswald, B., Maier, K., Karg, E. W., & Ramseger, R. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09012fp · Cited by 24
Biosynthesis, metabolism and function of protectins and resolvins
Demarquoy, J., & Borgne, F. L. (2014) · Clinical Lipidology · doi:10.2217/clp.14.44 · Cited by 27
Shi, Z., Ye, W., Zhang, J., Zhang, F., Yu, D., Yu, H., Chen, B., Zhou, M., & Sun, H. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.09.003 · Cited by 24
“LXA4 is an important endogenous anti-inflammatory lipid mediator and has been extensively studied preclinically in inflammatory diseases (Schmidt, 2001; Serhan, 1994).”
BackgroundSiegel, E. R., Croze, R. H., Fang, X., Matthay, M. A., & Gotts, J. E. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00046.2021 · Cited by 23
Lipoxin A4 activates ALX/FPR2 to attenuate inflammation in Aspergillus fumigatus keratitis
Zhu, X., Peng, X., Lin, J., Zhang, Y., He, H. Z., & Zhao, G. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107785 · Cited by 22
Abdalla, H. B., Luciano Eduardo, P. U. H. L., Rivas, C. A., Wu, Y., Rojas, P., Trindade‐da‐Silva, C. A., Hammock, B. D., Maddipati, K. R., Soares, M. Q. S., Clemente‐Napimoga, J. T., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300650 · Cited by 24
Yudina, Y., Parhamifar, L., Bengtsson, A. M.-L., Juhas, M., & Sjölander, A. (2008) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.09.024 · Cited by 22
Novel Resolution Mediators of Severe Systemic Inflammation
Gudernatsch, V., Stefanczyk, S. A., & Mirakaj, V. (2020) · ImmunoTargets and Therapy · doi:10.2147/itt.s243238 · Cited by 27
Immune parameters differentiating active from latent tuberculosis infection in humans
Lee, J. Y., Jung, Y. W., Jeong, I., Joh, J.-S., Sim, S. Y., Choi, B., Jee, H., & Lim, D. (2015) · Tuberculosis · doi:10.1016/j.tube.2015.08.003 · Cited by 22
“Considering that both PGE2 and LXA4 are generated from lipid metabolism of the plasma membrane, the rate of which is greatly influenced by the level of inflammation [32,33], the high PGE2 in ATB might be due to the strong inflammatory milieu elicited by actively replicating Mtb.”
BackgroundHori, T., Ishijima, J., Yokomizo, T., Ago, H., Shimizu, T., & Miyano, M. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj176 · Cited by 22
Albumin to globulin ratio and/or plasma albumin in predicting long-term mortality
Das, U. N. (2014) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2013.08.055 · Cited by 22
Bioactive lipid mediator class switching regulates myogenic cell progression and muscle regeneration
Fabre, P., Molina, T., Larose, J., Greffard, K., Généreux-Gamache, G., Deprez, A., Mokhtari, I., Pellerito, O., Duchesne, É., Dort, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60586-8 · Cited by 25
“During the onset phase of acute in fl ammation, PUFAs are initially converted into pro-in fl ammatory bioactive lipids (e.g., prostaglandins, leukotrienes) during the fi rst few hours or days post-injury (dpi) 11 .”
InfluentialThe Inflammatory Role of Pro-Resolving Mediators in Endometriosis: An Integrative Review
de Fáveri, C., Fermino, P. M. P., Piovezan, A. P., & Volpato, L. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094370 · Cited by 23
“In addition, several studies show its influence on the pathogenesis of endometriosis [9].”
BackgroundDifferences in oxylipin profile in psoriasis versus psoriatic arthritis
Coras, R., Kavanaugh, A., Kluzniak, A., Holt, D., Weilgosz, A., Aaron, A., Quehenberger, O., Ritchlin, C. T., & Gumá, M. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02575-y · Cited by 21
“However, it is also involved in the activation of the resolution of inflammation, by stimulating the secretion of specialized pro-resolving mediators [17].”
BackgroundLiu, Y., Wei, L., He, C., Chen, R., & Meng, L. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109660 · Cited by 21
Apoptotic cell-derived metabolites in efferocytosis-mediated resolution of inflammation
Mao, Y. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.10.002 · Cited by 23
Resolution-promoting autacoids demonstrate promising cardioprotective effects against heart diseases
Hiram, R. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07230-6 · Cited by 24
Johnson, R. K., Manke, J., Campbell, M., Armstrong, M., Boorgula, M. P., Pinheiro, G. P., Santana, C. V. N., Mathias, R. A., Barnes, K. C., Cruz, Á. A., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.02.026 · Cited by 22
BRAF Modulates Lipid Use and Accumulation
Turner, J. A., Paton, E. L., Gulick, R. J. V., Stefanoni, D., Cendali, F. I., Reisz, J. A., Tobin, R. P., McCarter, M. D., D’Alessandro, A., Torres, R. M., et al. (2022) · Cancers · doi:10.3390/cancers14092110 · Cited by 28
“These 20-carbon PUFAs are able to serve as precursors for lipids mediators that play important roles in pro-resolving inflammation (also described as type II inflammation) [33].”
BackgroundHöglund, N., Nieminen, P., Mustonen, A., Käkelä, R., Tollis, S., Koho, N. M., Holopainen, M., Ruhanen, H., & Mykkänen, A. K. (2023) · Scientific Reports · doi:10.1038/s41598-023-36697-x · Cited by 21
Insufficient Resolution Response in the Hippocampus of a Senescence-Accelerated Mouse Model — SAMP8
Wang, X., Puerta, E., Cedazo-Mínguez, Á., Hjorth, E., & Schultzberg, M. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0346-z · Cited by 24
“In a skin inflammation model, the increased biosynthesis of LXA4 in the inflammation site shortly after the peak of proinflammatory activities demonstrates a typical programmed resolution response to inflammation (Levy et al. 2001).”
BackgroundInfluentialPlagge, M., & Laskay, T. (2017) · BioMed Research International · doi:10.1155/2017/2014583 · Cited by 24
A High Docosahexaenoic Acid Diet Alters the Lung Inflammatory Response to Acute Dust Exposure
Dominguez, E. C., Heires, A. J., Pavlik, J. A., Larsen, T. D., Guardado, E. S., Sisson, J. H., Baack, M. L., Romberger, D. J., & Nordgren, T. M. (2020) · Nutrients · doi:10.3390/nu12082334 · Cited by 23
Wang, C., Xiao, M., Liu, X., Chen, N., Liu, J., Erben, U., & Qin, Z. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2801 · Cited by 21
Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease?
Das, U. N. (2008) · Lipids in Health and Disease · doi:10.1186/1476-511x-7-19 · Cited by 23
“Hs-CRP, LP-LPA2, ROS, and MPO have cytotoxic actions, whereas LXs, resolvins, protectins, and nitrolipids show cytoprotective and cardioprotective actions, in view of their ability to inhibit production of IL-6 and TNF-α, suppress free radical generation, and enhance tissue repair [4,12-24,26-28].”
BackgroundImmune and inflammatory responses to freediving calculated from leukocyte gene expression profiles
Eftedal, I., Flatberg, A., Drviš, I., & Dujić, Ž. (2016) · Physiological Genomics · doi:10.1152/physiolgenomics.00048.2016 · Cited by 22
“ation was that for inhibition of neutrophil migration by proresolving lipid mediators, an anti-inflammatory process that limits airway inflammation caused by transendothelial migration and accumulation of neutrophils in chronic obstructive pulmonary disease (20).”
BackgroundBuchmann, R., Hasilík, A., Dyke, T. E. V., & Lange, D. E. (2002) · Journal of Periodontology · doi:10.1902/jop.2002.73.9.995 · Cited by 21
Turi, K. N., Michel, C. R., Manke, J., Doenges, K., Reisdorph, N. A., & Bauer, A. K. (2023) · Metabolites · doi:10.3390/metabo13030406 · Cited by 23
Rao, Z., Caprioglio, D., Gollowitzer, A., Kretzer, C., Imperio, D., Collado, J. A., Waltl, L., Lackner, S., Appendino, G., Muñóz, E., et al. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115202 · Cited by 21
Resolvin D2 limits atherosclerosis progression via myeloid cell‐GPR18
Lipscomb, M., Walis, S., Marinello, M., Mena, H. A., MacNamara, K. C., Spite, M. R., & Fredman, G. (2024) · The FASEB Journal · doi:10.1096/fj.202302336rr · Cited by 23
Neuroprotective Effects of Lipoxin A4 in Central Nervous System Pathologies
Martini, A. C., Forner, S., Bento, A. F., & Rae, G. A. (2014) · BioMed Research International · doi:10.1155/2014/316204 · Cited by 20
“In fact, their formation and functions are directly linked to a change in the phenotype of neutrophils present at the site of inflammation [20].”
BackgroundContributions of neutrophils to resolution of mucosal inflammation
Colgan, S. P., Ehrentraut, S., Glover, L. E., Kominsky, D. J., & Campbell, E. L. (2012) · Immunologic Research · doi:10.1007/s12026-012-8350-2 · Cited by 22
Espinosa, G., Plaza, A., Schenffeldt, A., Alarcón, P., Gajardo, G., Uberti, B., Morán, G., & Henríquez, C. (2019) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2019.109975 · Cited by 22
Bodhale, N. P., Ohms, M., Ferreira, C., Mesquita, I., Mukherjee, A., André, S., Sarkar, A., Estaquier, J., Laskay, T., Saha, B., et al. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155267 · Cited by 24
Fischer, C. D., Duquette, S. C., RENAUX, B. S., Feener, T. D., Morck, D. W., Hollenberg, M. D., Lucas, M. J., & Buret, A. G. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02813-14 · Cited by 24
“mediators, such as PGE2, increase the expression of 15-LO in neutrophils, allowing these cells to synthesize LXs on their own (50),”
BackgroundClues for new therapeutics in osteoporosis and periodontal disease: new roles for lipoxygenases?
Serhan, C. N. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.6.643 · Cited by 20
“Given the now-appreciated contributions of focal oral inflammation and oral hygiene to cardiovascular disease [43], and the heightened awareness that inflammation is a key component contributing to cardiovascular disease [36], it is possible that enhancing endogenous anti-inflammation and resolution [11,14] via LX and…”
BackgroundResultInfluentialSelf-citationThe utilisation of resolvins in medicine and tissue engineering
Blaudez, F., Ivanovski, S., Fournier, B., & Vaquette, C. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.11.047 · Cited by 19
A matter of time: temporal structure and functional relevance of macrophage metabolic rewiring
Seim, G. L., & Fan, J. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.02.005 · Cited by 23
The hypoxic tissue microenvironment as a driver of mucosal inflammatory resolution
Cartwright, I. M., & Colgan, S. P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1124774 · Cited by 19
“Early in the inflammatory response, PMN recruitment and transmigration triggers lipid mediator classswitching resulting in the metabolism of PUFA into arachidonic acid and ultimately lipoxin, a pro-resolving mediator (109).”
BackgroundLacy, S. H., Woeller, C. F., Thatcher, T. H., Maddipati, K. R., Honn, K. V., Sime, P. J., & Phipps, R. P. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00272.2016 · Cited by 21
Immunoregulatory role of 15‐lipoxygenase in the pathogenesis of bacterial keratitis
Carion, T. W., Greenwood, M., Ebrahim, A. S., Jerome, A. D., Suvas, S., Gronert, K., & Berger, E. A. (2018) · The FASEB Journal · doi:10.1096/fj.201701502r · Cited by 19
“More specifically, PGE2 has been shown to induce LXA4 formation in PMNs (36).”
BackgroundSelf-citationMani, A. M., Chattopadhyay, R., Singh, N. K., & Rao, G. N. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.068 · Cited by 20
Protective effect of luteolin on acute lung injury in a rat model of sepsis
Çelebi, D., Aydın, P., Çınar, İ., Kutlu, Z., Çalık, İ., Halıcı, Z., Bilici, D., & Bayraktutan, Z. (2020) · Biotechnic & Histochemistry · doi:10.1080/10520295.2020.1846787 · Cited by 20
“Although secretion of IL-10 during sepsis is beneficial initially, it later increases the sepsis score and sepsis related deaths by reducing inflammatory defenses and suppressing the immune response (Levy et al. 2001).”
BackgroundKertaoui, N. E., Lund, I., Betancor, M. B., Carpentier, C., Montero, D., & Kestemont, P. (2021) · Aquaculture · doi:10.1016/j.aquaculture.2021.737060 · Cited by 18
“Thus, the resulted higher expression levels of i-fabp gene in high DHA fish group may indicate the enhancement of fatty acid transfer rate and absorption (Baier et al., 1996; Levy et al., 2001; Storch and Thumser, 2010).”
BackgroundThe Role of Innate Immunity and Bioactive Lipid Mediators in COVID-19 and Influenza
Sahanic, S., Löffler‐Ragg, J., Tymoszuk, P., Hilbe, R., Demetz, E., Masanetz, R. K., Theurl, M., Holfeld, J., Gollmann‐Tepeköylü, C., Tzankov, A., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.688946 · Cited by 19
Behnke, M., Klemm, P., Dahlke, P., Shkodra, B., Beringer-Siemers, B., Czaplewska, J. A., Stumpf, S., Jordan, P. M., Schubert, S., Hoeppener, S., et al. (2023) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2023.100173 · Cited by 22
“Such dual inhibitors of FLAP/mPGES-1 belong to a recently established class of anti-inflammatory drugs known as Lipid Mediator Class Switch Inducers (LMCSIs) (Kretzer et al., 2022; Levy et al., 2001; Serhan et al., 2014).”
BackgroundGranulocyte development, tissue recruitment, and function during allergic inflammation
Radtke, D., & Voehringer, D. (2023) · European Journal of Immunology · doi:10.1002/eji.202249977 · Cited by 24
Bascuñán, K. A., Araya, M., Rodríguez, J. M., Roncoroni, L., Elli, L., Alvarez, J. D. P. L., & Valenzuela, R. (2025) · Nutrients · doi:10.3390/nu17040621 · Cited by 21
Das, U. N. (2011) · World Journal of Diabetes · doi:10.4239/wjd.v2.i11.176 · Cited by 20
The Role of Fish Oil in Inflammatory Eye Diseases
Wang, H., & Daggy, B. P. (2017) · Biomedicine Hub · doi:10.1159/000455818 · Cited by 21
Unconventional therapies for hidradenitis suppurativa
Marasca, C., Annunziata, M. C., Napolitano, M., & Fabbrocini, G. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1509706 · Cited by 18
The Resolution of Intestinal Inflammation: The Peace-Keeper’s Perspective
Onali, S., Favale, A., & Fantini, M. C. (2019) · Cells · doi:10.3390/cells8040344 · Cited by 20
Ungaro, F., D’Alessio, S., & Danese, S. (2020) · Cancers · doi:10.3390/cancers12082060 · Cited by 19
“lipoxins, resolvins, and protectins) to induce the resolution of inflammation [33,34].”
BackgroundCorazza, B. J. M., Martinho, F. C., Khoury, R. D., Toia, C. C., Orozco, E. I. F., do Prado, R. F., Machado, F. P., & Valera, M. C. (2020) · International Endodontic Journal · doi:10.1111/iej.13403 · Cited by 19
SAA and PLTP activity in plasma of periodontal patients before and after full‐mouth tooth extraction
Vuletic, S., Taylor, B., Tofler, G. H., Chait, A., Marcovina, S., Schenck, K., & Albers, J. (2008) · Oral Diseases · doi:10.1111/j.1601-0825.2007.01411.x · Cited by 23
Scully, M., Gang, C., Condron, C. M., Bouchier‐Hayes, D. M., & Cunningham, A. J. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.02.020 · Cited by 18
Ağış, E. R., Savaş, B., & Melli, M. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.04.001 · Cited by 18
Anstead, G. M., Zhang, Q., & Melby, P. C. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.04.011 · Cited by 18
“PGs may also shift AA into the 15-LO pathway, which also generates anti-inflammatory lipid mediators [69].”
BackgroundSerial Changes in Plasma Annexin A1 and Cortisol Levels in Sepsis Patients
Tsai, W., Li, I.-T., Yu, Y.-B., Hsu, H.-C., & Shih, C.-H. (2014) · The Chinese Journal of Physiology · doi:10.4077/cjp.2014.bab193 · Cited by 20
The essential role of annexin A1 mimetic peptide in the skin allograft survival
Teixeira, R. A. P., Mimura, K. K. O., Araújo, L. P., Greco, K. V., & Oliani, S. M. (2013) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1773 · Cited by 18
“For this reason, research has been carried out aimed at developing new drugs and mediators responsible for regulating the mechanisms of cell migration (Perretti, 1997; Levy et al., 2001; Gil et al., 2006; Araujo et al., 2012).”
BackgroundKolawole, O. R., & Kashfi, K. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177924 · Cited by 21
The Clinical Significance of Low Serum Arachidonic Acid in Sepsis Patients with Hypoalbuminemia
Yamaguchi, J., Kinoshita, K., Ihara, S., Furukawa, M., & Sakurai, A. (2018) · Internal Medicine · doi:10.2169/internalmedicine.9124-17 · Cited by 22
“Under physiological conditions albumin could mobilize FAs from the liver and promote anti-inflammatory compounds such as lipoxins, resolvins, and protectins, which are metabolized from omega-3 fatty acids (7, 16, 17).”
Background12/15-Lipoxygenase choreographs the resolution of IgG-mediated skin inflammation
Sezin, T., Ferreirós, N., Jennrich, M., Ochirbold, K., Seutter, M., Attah, C., Mousavi, S., Zillikens, D., Geißlinger, G., & Sadik, C. D. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102528 · Cited by 18
Anh, T. T. V., Alilou, M., Rao, Z., Pace, S., Schwaiger, S., Kretzer, C., Temml, V., Giesel, C., Jordan, P. M., Bilancia, R., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.011 · Cited by 20
Metadata
- Authors
- Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Serhan, Charles N.
- Venue
- Nature Immunology
- Published
- 2001-07
- Volume
- 2
- Issue
- 7
- Pages
- 612-619
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1497700962
- Cited by
- 1,453
- References
- 42
- Citations by year
- 2026: 48 · 2025: 60 · 2024: 61 · 2023: 74 · 2022: 74 · 2021: 81 · 2020: 76 · 2019: 64 · 2018: 69 · 2017: 62 · 2016: 62 · 2015: 63 · 2014: 62 · 2013: 69 · 2012: 60
- FWCI
- 33.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k08hl003788-04)
- National Heart, Lung, and Blood Institute (K08 HL 03788)
- National Institute of General Medical Sciences (GM 38765)
- National Institute of Allergy and Infectious Diseases (F32AI010389, F32-AI10389)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-50305, P01DK050305, K01DK060583)
- National Institute of Dental and Craniofacial Research (P01 DE 13499, P01DE013499)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- lipid mediators, acute inflammation, inflammation resolution, leukotrienes, prostaglandins, lipoxins, eicosanoid biosynthesis, neutrophil recruitment, lipoxin A4, leukotriene B4, 5-lipoxygenase, 15-lipoxygenase, prostaglandin E2, exudate, anti-inflammatory signaling
- MeSH terms
- Animals, Arachidonate 15-Lipoxygenase, Base Sequence, Humans, Hydroxyeicosatetraenoic Acids, Leukotriene B4, Lipids, Male, Mice, Inbred BALB C, Molecular Sequence Data, Neutrophils, Pleural Effusion, RNA, Messenger, Dinoprostone, Molecular Structure, Signal Transduction, DNA, Complementary, Lipoxins, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.